Morgan Stanley’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-169
Closed -$1.14K – 8698
2026
Q1
$1.14K Buy
+169
New +$4.63K ﹤0.01% 7415

Other funds holding CRCD

Morgan Stanley's CRCD Position: Q2 2026 in Review

Morgan Stanley sold out of T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q2 2026, closing a stake of 169 shares — an estimated $1.14K sold.

Morgan Stanley first reported a position in CRCD in Q1 2026 and held it in 1 quarter. The position peaked at $1.14K in Q1 2026. 12 funds tracked by Wall St. Rank hold CRCD as of Q2 2026.

  • Morgan Stanley reported no remaining T-REX 2X Inverse CRCL Daily Target ETF position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 169 T-REX 2X Inverse CRCL Daily Target ETF shares in Q2 2026, an estimated $1.14K.
  • Morgan Stanley first reported a position in T-REX 2X Inverse CRCL Daily Target ETF in Q1 2026 and held it in 1 quarter.
  • Morgan Stanley's T-REX 2X Inverse CRCL Daily Target ETF position peaked at $1.14K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.